KidneyCure
Company

Last deal

$4M

Amount

Venture - Series Unknown

Stage

18.11.2018

Date

1

all rounds

$4M

Total amount

date founded

Financing round

General

About Company
KidneyCure is developing proprietary cell therapies to prevent Chronic Kidney Disease progression.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2009

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

The company's approach is based on pioneering research by Nephrology expert Prof. Benjamin Dekel at Sheba Medical Center. KidneyCure's 3D renal cell cluster technology is designed to delay the need for dialysis and transplantation, improve kidney function, prevent fibrotic renal tissue formation, and delay disease progression. The company's personalized drugs leverage autologous, revitalized renal progenitor cells to provide patients with a substantial delay in the need for dialysis and kidney transplantation, ultimately improving their quality of life.
Similar Companies
1000
AlloCure

AlloCure

AlloCure develops cell therapies for kidney diseases, organ transplants, and multi-organ injuries.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology, Medical

Location

Burlington, MA, USA

total rounds

5

total raised

$46.99M
Thrasos

Thrasos

Thrasos develops targeted therapies for severe organ failures.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Dorval, QC, Canada

total rounds

2

total raised

$56M
Bellus Health

Bellus Health

BELLUS Health develops drugs for rare diseases, starting with kidney conditions.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Laval, QC, Canada

total rounds

8

total raised

$372.06M
Regentys

Regentys

Regentys is a regenerative medicine company that develops treatments for gastrointestinal disorders..

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Miami Lakes, FL, USA

total rounds

3

total raised

$1.4M

Financials

Funding Rounds
1
1

Number of Funding Rounds

$4M

Money Raised

Their latest funding was raised on 18.11.2018. Their latest investor Aurum Ventures MKI. Their latest round Venture - Series Unknown

Date 
Funding Round 
Investors 
Money Raised 
Lead 
Aurum Ventures MKI

Aurum Ventures MKI

Aurum Ventures MKI provides value-added growth capital to exceptional entrepreneurs in life sciences and clean tech.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Biotechnology, Financial Services

Location

Ramat Gan, Israel

count Of Investments

6

count Of Exists

1
Co-Investors
Investors
1
1

Number of lead investors

1

Number of investors

Investor 
Lead 
Round 
Partners 
Yes
Venture - Series Unknown
Aurum Ventures MKI

Aurum Ventures MKI

Aurum Ventures MKI provides value-added growth capital to exceptional entrepreneurs in life sciences and clean tech.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Biotechnology, Financial Services

Location

Ramat Gan, Israel

count Of Investments

6

count Of Exists

1
Morris Kahn

Morris Kahn

Mr. Morris Kahn, born in South Africa, is the founder of the Aurec Group, a leading provider of communications, media and information services in Israel and worldwide: Aurec Group and its affiliates consisted of several leading companies in Israel among which are Amdocs, Golden Pages, and AIG Golden Insurance. Amdocs, one of Israel's largest software companies, with more than 20,000 employees worldwide and customers in more than fifty countries, providing integrated customer management to the Telecom and Television industries. Morris’s passion to the sea, diving, marine life and its preservation led him to found the Coral World International, which owns and manages underwater observatories and marine parks in Israel and around the world. In recent years Mr. Kahn has focused on philanthropy and venture philanthropy under the patronage of "The Kahn Foundation" in the fields: education, leadership, health, medicine, science and environment.

current job

SpaceIL
SpaceIL

count Of Investments

4

People

Employee Profiles
3
Benjamin Dekel

Benjamin Dekel

Founder

Dr. Alon Yaar

CEO

Orit Harari-Steinberg

Orit Harari-Steinberg

Co Founder & Director of Research and Development

Activity

Recent News
0